# Rivastigmine Tartrate (Rivastigmine Tartrate)

Source: https://ourhealthnetwork.com/drugs/rivastigmine-tartrate
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Rivastigmine Tartrate?

Rivastigmine Tartrate is a cholinesterase inhibitor. It is prescribed to treat alzheimer disease. Across the United States, 8,000 doctors prescribe Rivastigmine to approximately 18,000 Medicare patients.

## Brand names

Rivastigmine Tartrate

## Indications

Rivastigmine Tartrate is primarily prescribed for the treatment of alzheimer disease.

## Conditions treated

- [Alzheimer Disease](https://ourhealthnetwork.com/conditions/alzheimer-disease)

## Mechanism of action

Although the precise mechanism of action of rivastigmine is unknown, it is thought to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by cholinesterase.

## Drug classification

- Established Pharmacologic Class: cholinesterase inhibitors
- Route of administration: ORAL

## Common side effects

asthenia, dyspepsia, nausea, vomiting

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)